Literature DB >> 32621547

The role of long non-coding RNAs and downstream signaling pathways in leukemia progression.

Yadong Liu1, Penghao Sun2, Yuhao Zhao3, Bin Liu4.   

Abstract

The study of long non-coding RNAs (lncRNA) is a newly established field and our knowledge about them is rapidly growing. These kinds of RNAs are unchanged parts of the genome throughout evolution, that modulate cell growth, differentiation, and apoptosis during diverse physiological and pathological processes including leukemia development. They have the capability to be useful biomarkers for the diagnosis, clinical typing, prognosis, as well as potential therapeutic targets. In this study, we summarized the role of lncRNAs in the expression and function of white blood cells and oncogenic transformation into four main types of leukemia.
© 2020 John Wiley & Sons Ltd.

Entities:  

Keywords:  ALL; AML; CLL; CML; leukemia; long non-coding RNAs

Mesh:

Substances:

Year:  2020        PMID: 32621547     DOI: 10.1002/hon.2776

Source DB:  PubMed          Journal:  Hematol Oncol        ISSN: 0278-0232            Impact factor:   5.271


  3 in total

1.  LINC00265/miR-4500 Axis Accelerates Acute Lymphoblastic Leukemia Progression by Enhancing STAT3 Signals.

Authors:  Donglu Zhao; Qi Xing; Hang Song; Yan Zhao; Guiying Guo
Journal:  Cancer Manag Res       Date:  2021-10-28       Impact factor: 3.989

2.  Expression Profiles of Long Non-Coding RNA GAS5 and MicroRNA-222 in Younger AML Patients.

Authors:  Djordje Pavlovic; Natasa Tosic; Branka Zukic; Zlatko Pravdic; Nada Suvajdzic Vukovic; Sonja Pavlovic; Vladimir Gasic
Journal:  Diagnostics (Basel)       Date:  2021-12-30

3.  m(6)A Modification of lncRNA NEAT1 Regulates Chronic Myelocytic Leukemia Progression via miR-766-5p/CDKN1A Axis.

Authors:  Fang-Yi Yao; Cui Zhao; Fang-Min Zhong; Ting-Yu Qin; Fang Wen; Mei-Yong Li; Jing Liu; Bo Huang; Xiao-Zhong Wang
Journal:  Front Oncol       Date:  2021-07-20       Impact factor: 6.244

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.